| English |
Deutsch |
| usage |
Sprachgebrauch |
| hexahydro-2H-azepin-2-one, and |
Hexahydro-2H-azepin-2-on und |
| (2.alpha.,4a.alpha.,8.alpha.)-hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalen-8(5H)-one |
(2α,4aα,8α)-Hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalin-8(5H)-on |
| (hexahydro-2H-azepin-2-ylidene)bis(phosphonic) acid |
(Hexahydro-2H-azepin-2-yliden)bis(phosphon)säure |
| 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; |
reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; |
| 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; |
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; |
| N-[4-[[[(6S)-2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-L-glutamic acid, glucosamine salt |
N-[4-[[[(6S)-2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-L-Glutaminsäure, Glucosaminsalz |
| 1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-,[3aS-(3a.alpha.,4.beta.,6a.alpha.)]- |
1H-Thieno[3,4-d]imidazol-4-pentansäure, Hexahydro-2-oxo-,[3aS-(3aα,4β,6aα)]- |
| mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; |
Gemisch aus: 4-(1,3a,4,6,7,7a-Hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol; |
| (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene (isodrin-ISO) |
1,2,3,4,10,10-Hexachlor-1,4,4a,5,8,8a-hexahydro-1,4; 5,8-endo-endo-dimethanonaphthalin (Isodrin - ISO) |
| The row relating to the substance ‘(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-tetramethrin’ shall be replaced by the following text |
:Die Zeile zum Stoff „(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Tetramethrin“ wird durch folgenden Text ersetzt: |
| Urea, (2,5-dioxo-4-imidazolydinyl)-, compound with 2H-thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, [3as-(3aalpha,4b,6aalpha)]- |
Harnstoff, (2,5-Dioxo-4-Imidazolydinyl)-, Verbindung mit 2H-Thieno[3,4-d]Imidazol-4-Pentansäure, Hexahydro-2-Oxo-, [3as-(3aα,4b,6aα)]- |
| Deutsch |
English |
| Sprachgebrauch |
usage |
| Hexahydro-2H-azepin-2-on und |
hexahydro-2H-azepin-2-one, and |
| (2α,4aα,8α)-Hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalin-8(5H)-on |
(2.alpha.,4a.alpha.,8.alpha.)-hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalen-8(5H)-one |
| (Hexahydro-2H-azepin-2-yliden)bis(phosphon)säure |
(hexahydro-2H-azepin-2-ylidene)bis(phosphonic) acid |
| reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; |
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; |
| 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; |
1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; |
| N-[4-[[[(6S)-2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-L-Glutaminsäure, Glucosaminsalz |
N-[4-[[[(6S)-2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-L-glutamic acid, glucosamine salt |
| 1H-Thieno[3,4-d]imidazol-4-pentansäure, Hexahydro-2-oxo-,[3aS-(3aα,4β,6aα)]- |
1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-,[3aS-(3a.alpha.,4.beta.,6a.alpha.)]- |
| Gemisch aus: 4-(1,3a,4,6,7,7a-Hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol; |
mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; |
| 1,2,3,4,10,10-Hexachlor-1,4,4a,5,8,8a-hexahydro-1,4; 5,8-endo-endo-dimethanonaphthalin (Isodrin - ISO) |
(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene (isodrin-ISO) |
| :Die Zeile zum Stoff „(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Tetramethrin“ wird durch folgenden Text ersetzt: |
The row relating to the substance ‘(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-tetramethrin’ shall be replaced by the following text |
| Harnstoff, (2,5-Dioxo-4-Imidazolydinyl)-, Verbindung mit 2H-Thieno[3,4-d]Imidazol-4-Pentansäure, Hexahydro-2-Oxo-, [3as-(3aα,4b,6aα)]- |
Urea, (2,5-dioxo-4-imidazolydinyl)-, compound with 2H-thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, [3as-(3aalpha,4b,6aalpha)]- |
